NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
Author: Global Cancer Consortium
This week, OneMedRadio brings you two management interviews. Iconic Data, CEO David LaBorde discusses their lead product SwiftPayMD and why it is changing the face of patient billing. Opexa CEO, Neil Warma discusses a potential blockbuster treatment in numerous autoimmune diseases. In addition, we bring you part II of Healthcare’s Digital Revolution and three new treatments for Prostate Cancer. Sincerely, Brett Johnson
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
In this special series we present emerging technologies which hold the promise to significantly improve the prognosis of patients diagnosed with prostate cancer, and cancer in general.
Author of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Healthcare”, Dr. Eric Topol sits down with OneMedRadio to discuss the ideas and inspiration behind the book.
The New York Biotech Association Annual Meeting last Wednesday and Thursday was a success, showcasing 15 emerging companies as well as two dozen panels over the two-day span. Held in the Marriott Marquis Hotel, a staple of Times Square, the 21st annual conference was well attended.
Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments.
This week, OneMedPlace brings you a special report on CIN. In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN. In addition, OneMedRadio interviews Dr. Andrew Senyei on gene therapeutics and diagnostics, and editor, Matt Margolis investigates 3 companies that could eradicate the Ebola virus. OneMedPlace is gearing up for our first partnership in NYBA’s Annual Biotechnology Conference to be held tomorrow in New York City. If interested in attending, please click here, or call 212-734-1008. Hope to see you there! Sincerely, Brett…